Adaptimmune Ther ADR (ADAP)

$1.19 0.00 (0.00%)
16:00 EDT ADAP Stock Quote Delayed 30 Minutes

ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings
ADAP stock results show that Adaptimmune Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 1.76B
PE Ratio -14.88
EPS -0.08
Volume (Avg. Vol.)
Day's Range -
52-Week Range $0.42 - $2.05
Dividend & Yield N/A (N/A)